HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anti-proliferative effects of unmodified antisense oligodeoxynucleotides targeted against c-raf mRNA: use of poly (lysine/serine) copolymers or cationic lipopolyamines.

Abstract
1. It is now known that nuclease-resistant phosphorothioate antisense oligodeoxynucleotides (ODN) have some actions that are unrelated to antisense mechanisms. In the present study we assessed the anti-proliferative effects of phosphorothioate (PS) and phosphodiester (PO; unmodified) antisense ODN targeted against c-raf mRNA on pancreatic cancer cells in vitro, using poly (lysine/serine) copolymers conjugated with polyethylene glycol (PLSP) or cationic lipopolyamines (Transfectam) as carriers. 2. The anti-proliferative effect of the PO antisense ODN was significantly (P < 0.05) greater than that of the PS ODN, either complexed with PLSP (2 mumol/L ODN) or the Transfectam (0.5 mumol/L ODN). However, the effect of the PS or PO antisense ODN was not dependent on the antisense sequence. The c-raf mRNA levels, assessed by reverse transcription-polymerase chain reaction, were obviously reduced by both PO and PS antisense ODN compared with mismatched ODN when complexed with the Transfectam (1 mumol/L ODN). 3. Although the anti-proliferative effects were mainly unrelated to antisense mechanisms, unmodified antisense ODN complexed with some carriers could be used as anti-tumour agents considering that synthetic carriers can be modified to improve functions, such as delivery.
AuthorsY Aoki, S Kawa, Y Karasawa, A Horiuchi, K Kiyosawa
JournalClinical and experimental pharmacology & physiology (Clin Exp Pharmacol Physiol) Vol. 25 Issue 9 Pg. 702-5 (Sep 1998) ISSN: 0305-1870 [Print] Australia
PMID9750959 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cations
  • Drug Carriers
  • Oligonucleotides, Antisense
  • Peptides
  • Pharmaceutic Aids
  • Polyamines
  • RNA, Messenger
  • Thionucleotides
  • dioctadecylamidoglycylspermine
  • Polylysine
  • polyserine
  • Spermine
  • Polyethylene Glycols
  • Proto-Oncogene Proteins c-raf
  • Glycine
Topics
  • Cations
  • Cell Division (drug effects)
  • Drug Carriers
  • Glycine (administration & dosage, analogs & derivatives)
  • Humans
  • Oligonucleotides, Antisense (administration & dosage, pharmacology)
  • Pancreatic Neoplasms (drug therapy, pathology)
  • Peptides (administration & dosage)
  • Pharmaceutic Aids (pharmacology)
  • Polyamines (administration & dosage)
  • Polyethylene Glycols (administration & dosage)
  • Polylysine (administration & dosage)
  • Proto-Oncogene Proteins c-raf (genetics)
  • RNA, Messenger (metabolism)
  • Spermine (administration & dosage, analogs & derivatives)
  • Thionucleotides (administration & dosage, pharmacology)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: